...
首页> 外文期刊>The Lancet >Arrhythmogenic right ventricular cardiomyopathy.
【24h】

Arrhythmogenic right ventricular cardiomyopathy.

机译:心律失常性右室心肌病。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Arrhythmogenic right ventricular cardiomyopathy is a rare inherited heart-muscle disease that is a cause of sudden death in young people and athletes. Causative mutations in genes encoding desmosomal proteins have been identified and the disease is nowadays regarded as a genetically determined myocardial dystrophy. The left ventricle is so frequently involved as to support the adoption of the broad term arrhythmogenic cardiomyopathy. Clinical diagnosis can be achieved by demonstrating function and structure changes of the right ventricle, electrocardiogram depolarisation and repolarisation abnormalities, ventricular arrhythmias, and fibrofatty replacement through endomyocardial biopsy. Although specific, the standardised diagnostic criteria lack sensitivity for early disease and their primary application remains in establishing the diagnosis in probands. However, the main clinical targets are early detection of concealed forms and risk stratification for preventive strategies, which include physical exercise restriction, antiarrhythmic drugs, and implantable cardioverter-defibrillator therapy. Cascade genetic screening of family members of gene-positive probands allows the identification of asymptomatic carriers who would require lifelong follow-up due to the age-related penetrance.
机译:心律失常性右室心肌病是一种罕见的遗传性心肌病,是年轻人和运动员猝死的原因。已经鉴定出编码桥粒蛋白的基因中的致病突变,并且该疾病如今被认为是遗传确定的心肌营养不良。经常累及左心室,以支持采用广义的心律失常性心肌病。通过显示右心室的功能和结构变化,心电图去极化和复极化异常,室性心律不齐以及通过心内膜活检进行的纤维脂肪替代,可以实现临床诊断。尽管具体,但标准化的诊断标准对早期疾病缺乏敏感性,其主要应用仍在建立先证者的诊断中。但是,主要的临床目标是及早发现隐蔽形式和危险分层,以制定预防策略,包括体育锻炼限制,抗心律不齐药物和可植入的心脏复律除颤器疗法。对基因阳性先证者的家庭进行级联遗传筛选可以鉴定无症状携带者,这些携带者由于年龄相关的外在性而需要终生随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号